









Markets
/
Stocks
/
nasdaq-utmd
/

Utah Medical Products Inc

UTMD

61.640USD

-1.220-1.94%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

197.49MMarket Cap

17.40P/E TTM



Utah Medical Products Inc

61.640

-1.220-1.94%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Utah Medical Products Inc

Currency: USD Updated: 2026-02-06

Key Insights

Utah Medical Products Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 100 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Utah Medical Products Inc's Score

Industry at a Glance

Industry Ranking

100 / 205

Overall Ranking

268 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Utah Medical Products Inc Highlights

StrengthsRisks

Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

Growing

The company is in a growing phase, with the latest annual income totaling USD 40.90M.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 30.19%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 30.19%.

Fairly Valued

The company’s latest PE is 17.40, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 2.28M shares, decreasing 20.11% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 175.97K shares of this stock.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Utah Medical Products Inc is 9.46, ranking 6 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 9.81M, representing a year-over-year decrease of 1.93%, while its net profit experienced a year-over-year decrease of 26.16%.

Score

Industry at a Glance

Previous score

9.46

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.61

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.46

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.21

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Utah Medical Products Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Utah Medical Products Inc is 8.45, ranking 19 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 17.40, which is 27.28% below the recent high of 22.14 and 21.44% above the recent low of 13.67.

Score

Industry at a Glance

Previous score

8.45

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 100/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for Utah Medical Products Inc. The Healthcare Equipment & Supplies industry's average is 7.77.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Utah Medical Products Inc is 6.61, ranking 118 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 64.36 and the support level at 58.58, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.91

Change

-0.3

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.160

Neutral

RSI(14)

55.627

Neutral

STOCH(KDJ)(9,3,3)

50.254

Neutral

ATR(14)

1.945

High Vlolatility

CCI(14)

-18.693

Neutral

Williams %R

55.673

Sell

TRIX(12,20)

0.305

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

62.030

Sell

MA10

61.903

Sell

MA20

61.258

Buy

MA50

58.504

Buy

MA100

59.129

Buy

MA200

57.866

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Utah Medical Products Inc is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 71.63%, representing a quarter-over-quarter increase of 1.18%. The largest institutional shareholder is Brandes Investmen, holding a total of 337.93K shares, representing 10.61% of shares outstanding, with 42.21% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Brandes Investment Partners, L.P.

Star Investors

337.93K

+1.42%

Renaissance Technologies LLC

Star Investors

200.91K

-5.81%

Dimensional Fund Advisors, L.P.

200.03K

+1.30%

Cornwell (Kevin L)

188.47K

The Vanguard Group, Inc.

Star Investors

175.63K

-0.83%

BlackRock Institutional Trust Company, N.A.

157.18K

-0.47%

Hotchkis and Wiley Capital Management, LLC

Star Investors

109.00K

-2.63%

Minerva Advisors LLC

93.06K

Geode Capital Management, L.L.C.

89.96K

-21.65%

State Street Investment Management (US)

70.26K

+0.20%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Utah Medical Products Inc is 5.85, ranking 72 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.34. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Utah Medical Products Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.